slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 22,861-22,890
Pages 885
Rows per page 30
Arc
22,861-22,890 of 26,550
13
jetBlue | Investor Event Presentation Deck | 16 slidesjetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit
14
The slide uses the term 'BlueCity' to refer to specific airport locations being exited.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit
15
The slide presents a comprehensive list of route exits in a two-column table format.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit
16
jetBlue | Investor Event Presentation Deck | 16 slidesjetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit
07
Uses a 'before and after' visual comparison of a patient's health progression over time.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Problem Statement1 hit
08
The slide uses a three-column layout to explain the biological mechanisms of the drug combination.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
09
The slide shows a pharmacokinetic study in mice comparing Ciprofloxacin alone vs. combination therapy.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
10
Includes statistical significance markers (*, ***) and source citation.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
11
Includes a collaboration credit with Dr. Justin Ichida at USC.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
12
Includes box plots for baseline comparison and line charts for longitudinal treatment effects.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
13
Includes a flow diagram of the trial phases and a table of baseline characteristics.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
14
The slide highlights safety data; the bottom text emphasizes that adverse events were transient and anticipated.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
15
Includes statistical significance markers and sample sizes (N) for each time point.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
16
Includes both a longitudinal line chart and a bar chart comparing total points lost at 12 months.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
17
The slide compares 'DB' (Double Blind) and 'DB+OLE' (Double Blind + Open Label Extension) periods across four functional domains.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
18
The slide notes 'n.s.' (not statistically significant) for all metrics. The footer defines SVC and Survival calculation methodology.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
19
Includes longitudinal biomarker charts and correlation scatter plots with p-values.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
20
The slide uses a bulleted list to present key clinical trial outcomes, including p-values and percentage improvements.NeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
22
NeuroSense Therapeutics | Investor Presentation Deck | 27 slidesNeuroSense Therapeutics | Investor Presentation Deck | 27 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Market Sizing1 hit
10
Uses a funnel-like visual structure to connect specific operational issues to broader financial outcomes.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Problem (Identify pain)1 hit
11
Starboard Value | Activist Presentation Deck | 74 slidesStarboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
12
The chart uses a dashed box to highlight PFE and a dashed red line to indicate the peer median of 46 drugs.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
13
Uses authority bias to validate the activist's thesis that the company was already well-positioned for growth.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
14
The slide uses a series of quotes to establish a narrative of management over-promising on pipeline quality.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
15
The slide uses a quote to highlight a specific management commitment, likely to be contrasted with later performance.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
16
The slide is used by Starboard Value to contrast Pfizer's historical R&D projections with current performance.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
17
The slide uses a table to track 15 specific drug programs, noting their therapeutic area, next steps, and timing, with symbols indicating status (check for approval, star for designation, box for negative data).Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
18
The slide uses a table to highlight specific programs that had already achieved approvals or failed (negative pivotal data) to challenge the company's narrative.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
19
The slide uses a table from a third-party source (Pfizer) to build an activist argument about management performance.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
20
The slide uses a dashed line to represent the blockbuster threshold and includes a callout box explaining the donation of royalties.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit